ACM
AMPE

Anfield Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Anfield Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12
Closed -$2K – 416
2019
Q4 		$2K Buy
+12
New +$1.55K ﹤0.01% 387

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
HC
HNP Capital Rochester, New York $359M AUM 3.18% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Anfield Capital Management's AMPE Position: Q1 2020 in Review

Anfield Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2020, closing a stake of 12 shares — an estimated $2K sold.

Anfield Capital Management first reported a position in AMPE in Q4 2019 and held it in 1 quarter. The position peaked at $2K in Q4 2019. 77 funds tracked by Wall St. Rank hold AMPE as of Q1 2020.

  • Anfield Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2020 after selling out during the quarter.
  • Anfield Capital Management sold 12 Ampio Pharmaceuticals Inc. shares in Q1 2020, an estimated $2K.
  • Anfield Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2019 and held it in 1 quarter.
  • Anfield Capital Management's Ampio Pharmaceuticals Inc. position peaked at $2K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2020.

Based on Anfield Capital Management's 13F filing for Q1 2020, filed 7 May 2020.